Customer Remote Health Success Stories

What we did

Utilizing a wide range of mobile devices, an innovative and flexible population health advocate team at UVA, and deep integration into the Epic EMR (including ordering, discrete data utilization, and billing for RPM reimbursement), the UVA Health program is truly state-of-the art, supporting a wide range of adult and pediatric populations with both post-acute and chronic conditions.

Published Outcomes

Vergales BD, Murray PD, Miller SE, Vergales JE. Safety and efficacy of a home nasogastric monitoring program for premature infants. J Neonatal Perinatal Med. 2022;15(1):165-170. doi:10.3233/NPM-210790

Vergales J, Peregoy L, Zalewski J, Plummer ST. Use of a Digital Monitoring Platform to Improve Outcomes in Infants With a Single Ventricle. World J Pediatr Congenit Heart Surg. 2020;11(6):753-759. doi:10.1177/2150135120945596

Blair, L., Vergales, J., Peregoy, L., Seegal, H., & Keim-Malpass, J. (2022 Apr 1). Acceptability of an interstage home monitoring mobile application for caregivers of children with single ventricle physiology: Toward technology-integrated family management. Journal for Specialists in Pediatric Nursing, 27(3), e12372. https://doi.org/10.1111/jspn.12372.

Kennady, E., Nguyen, T., Caruso, J., Sims, T., Sun, F., Wilson, K., Thompson, N., Rellins, E., Culp, S., Ibilibor, C., Isharwal, S., Krupski, T., & Greene, K. (2023). Interactive Home Monitoring After Radical Cystectomy. The Journal of Urology, 209(4S), e268. https://doi.org/10.1097/JU.0000000000003244.09

What we're up to

During the COVID pandemic, Inova Schar Cancer Institute piloted an innovative RPM program to keep vulnerable patients undergoing chemotherapy from adverse events, a program for which strong outcomes were reported in the Journal of Clinical Oncology Practice. ISCI continues to work with Locus as a National Cancer Institute demonstration pilot site for Locus’ NIH/SBIR award and is establishing new standards of care for outpatient chemotherapy adverse event management using the Locus platform and a range of innovative mobile devices (e.g. AppleWatch).

Published Outcomes

Steimer M, Leabo J, Wang H, et al. Remote Home Monitoring of Patients With Cancer During the COVID Pandemic: A Pilot Study. JCO Oncol Pract. 2021;17(9):e1286-e1292. doi:10.1200/OP.20.00995

What we're doing

In particular, the BCH team is working with Locus to deliver the most innovative integration between RPM capabilities and the Epic EMR in Pediatrics, across an enterprise-wide range of acute and chronic pediatric populations.

What we're doing

Since 2020, Locus has been the recipient of Phase I and Phase II awards from the Small Business Innovation Research (SBIR) program sponsored by the National Institute of Health (NIH) through the National Cancer Institute (NCI). Locus was selected by NCI to commercialize its platform for use with Oncology patients by developing a Cancer Navigation Platform, pursuing a rigorous Phase I research effort and ongoing Phase II commercialization studies and technical research and development. Both UVA Cancer Center and Inova’s Schar Cancer Institute are deployment partners with Locus in this effort, and strategic advisors to the project include leaders from Cancer Centers at Duke, Ohio State, University of Kansas, and Yale. The current Phase II award is funded in its entirety under Federal Award (NIH/NCI) #75N91022C00038.

OSHU Health

Locus has partnered with Oregon Health & Science University (OHSU) Doernbecher Children’s Hospital since 2019 with their two pediatric populations serving High-Risk Cardiology patients and their NICU program, Growing @ Home. These programs enable eligible patients to be discharged sooner using the Locus software. Benefits go beyond early discharge, with savings to the families as well as freeing up more beds for more critical care babies who need it most.

Published Outcomes

Caruso CG, Warren JB, Carney PA. Parent experiences of a remote patient monitoring program enabling early discharge from the neonatal intensive care unit with nasogastric tube feeding. J Neonatal Perinatal Med. 2023;16(2):301-309. doi:10.3233/NPM-221181

Meet more of our customers

Why Locus

What our customers are saying

“The first question any parent asks when their child is admitted to the NICU is ‘When can we go home?’ Locus is allowing us to help some families return to their normal daily lives faster because we know babies thrive most in their home environment. It’s a real game changer.”

Dr. Cristina Miller,

Neonatologist at Children’s Minnesota

“After researching other remote monitoring platforms, there was no question that integrating Locus was hands down the best option for us. This turn-key program is unlike any other.”

Julie M. Stumpf, RN, MSN,

Manager Cardiac Neurodevelopment Clinic, St. Louis Children's Hospital

“The Locus Platform serves as a common thread that runs through all our Population Health programs…. The vital integration between Locus and our EMR platform, Epic, enables departments to automate orders and allows providers and care teams to see data in real-time…. Locus Health is an excellent partner.”